Back to results
US 2021/0060122 A1Published application
Method For Treating Cerebral Stroke
AssigneeSuzhou Yabao Pharmaceutical R&D Co., Ltd.
InventorsLei Yang, Guoning Lian, Xiaoping Gao, Lin Zhu
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of biomedicine, in particular to the use of annexin A5 in the treatment of cerebral stroke. The invention provides a method for treating cerebral stroke and a drug combination containing annexin A5. The method can reduce cerebral infarction, improve symptoms of neurobehavioral deficits in the brain and treating stroke.
Claims14
A method for treating cerebral stroke, comprising:
- administrating an annexin A5 or a functional equivalent thereof to a patient in need of such treatment.
A pharaceutical composition for treating cerebral stroke, comprising:
- an annexin A5 or a functional equivalent thereof.
A drug combination, comprising:
- (i) annexin A5 or a functional equivalent thereof;
- and
- (ii) an other drug for treating cerebral stroke other than (i).
Dependencies are inferred from the claim text.